Loss of function of SWI/SNF chromatin remodeling genes leads to genome instability of human lung cancer.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Oncology Report

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/or.2014.3584PMID 25370573
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The SWI/SNF genetic blockade: effects in cell differentiation, cancer and developmental diseases

  2014cited by this paper
• Association between smoking and p53 mutation in lung cancer: a meta-analysis.

  2014cited by this paper
• European cancer mortality predictions for the year 2014.

  2014cited by this paper
• Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer.

  2013cited by this paper
• Recurrent inactivating mutations of ARID2 in non‐small cell lung carcinoma

  2013cited by this paper
• European cancer mortality predictions for the year 2013.

  2013cited by this paper
• Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap)

  2013cited by this paper
• [Cancer statistics in the world].

  2013cited by this paper
• Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy

  2013cited by this paper
• Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010

  2013cited by this paper
• Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features

  2013cited by this paper
• Lung cancer in China: challenges and interventions.

  2013cited by this paper
• Year-in-Review of Lung Cancer

  2012cited by this paper
• SWI/SNF nucleosome remodellers and cancer

  2011cited by this paper
• Somatic Mutations in the Chromatin Remodeling Gene ARID1A Occur in Several Tumor Types

  2011cited by this paper
• Diverse Roles and Interactions of the SWI/SNF Chromatin Remodeling Complex Revealed Using Global Approaches

  2011cited by this paper
• Massive parallel DNA pyrosequencing analysis of the tumor suppressor BRG1/SMARCA4 in lung primary tumors

  2011cited by this paper
• SnapShot: Chromatin remodeling: SWI/SNF.

  2011cited by this paper
• Chromatin dynamics and the repair of DNA double strand breaks

  2011cited by this paper
• COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

  2010cited by this paper
• BRG1 co-localizes with DNA replication factors and is required for efficient replication fork progression

  2010cited by this paper
• Lung Cancer Genomic Signatures

  2010cited by this paper
• The SWI/SNF complex and cancer

  2009cited by this paper
• An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency

  2009cited by this paper
• Fluctuation AnaLysis CalculatOR: a web tool for the determination of mutation rate using Luria-Delbrück fluctuation analysis

  2009cited by this paper
• Brg1, the ATPase subunit of the SWI/SNF chromatin remodeling complex, is required for myeloid differentiation to granulocytes

  2006cited by this paper
• SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines

  2006cited by this paper
• The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

  2004cited by this paper
• Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation

  2001cited by this paper
• Molecular genetics of small cell lung carcinoma.

  2001cited by this paper
• The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern.

  1991cited by this paper
• A note on efficient estimation of mutation rates using Luria-Delbrück fluctuation analysis.

  1991cited by this paper

• Mutational landscape of epidermoid carcinoma of the penis in a Brazilian cohort

  2025cites this paper
• Genomic pathogenic alterations in the SWI/SNF complex compromise the outcomes of immunotherapy in Chinese patients with KRAS-mutant NSCLC by downregulating STING expression

  2025cites this paper
• Polarity protein Par3L deletion causes chromosomal segregation defects and tumorigenesis

  2025cites this paper
• Predicting hepatocellular carcinoma outcomes and immune therapy response with ATP-dependent chromatin remodeling-related genes, highlighting MORF4L1 as a promising target

  2025cites this paper
• Preclinical Evidence in the Assembly of Mammalian SWI/SNF Complexes: Epigenetic Insights and Clinical Perspectives in Human Lung Diseases Therapy.

  2024cites this paper
• SWI/SNF Complex Genomic Alterations as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Multiple Cancers

  2023cites this paper
• BCL11A Expression in Non-Small Cell Lung Cancers

  2023cites this paper
• ARID1A deficiency reverses the response to anti-PD(L)1 therapy in EGFR-mutant lung adenocarcinoma by enhancing autophagy-inhibited type I interferon production

  2022cites this paper
• Epigenetics alternation in lung fibrosis and lung cancer

  2022cites this paper
• Theoretical exploration of the binding selectivity of inhibitors to BRD7 and BRD9 with multiple short molecular dynamics simulations

  2022cites this paper
• Prevalence of SWI/SNF genomic alterations in cancer and association with the response to immune checkpoint inhibitors: a systematic review and meta-analysis.

  2022cites this paper
• The Impact of BCL11A Polymorphisms on Endometrial Cancer Risk Among Chinese Han Females

  2022cites this paper
• Targeting HSPA1A in ARID2-deficient lung adenocarcinoma

  2021cites this paper
• Genetic Variation and Recurrent Haplotypes on Chromosome 6q23-25 Risk Locus in Familial Lung Cancer

  2021cites this paper
• ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer

  2021cites this paper
• Genetic polymorphisms in gynecologic cancers

  2021cites this paper
• The clinicopathological features of BRG1-deficient non-small cell lung cancer and its response to immunotherapy: A single-center retrospective study.

  2021cites this paper
• The Clinicopathological Features of BRG1-de�cient Non-small Cell Lung Cancer and Its Response to Immunotherapy: A Single-center Retrospective Study

  2021cites this paper
• Functional Roles of Bromodomain Proteins in Cancer

  2021cites this paper
• Comprehensive genetic analysis confers high diagnostic yield in 16 Japanese patients with corpus callosum anomalies

  2021cites this paper
• Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis

  2021cites this paper
• The transcriptional repressor BCL11A promotes breast cancer metastasis

  2020cites this paper
• Exploiting epigenetic vulnerabilities in solid tumors: novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers.

  2020cites this paper
• Precision medicine and actionable alterations in lung cancer: A single institution experience

  2020cites this paper
• SMARCA4 mutations in KRAS‐mutant lung adenocarcinoma: a multi‐cohort analysis

  2020cites this paper
• Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer

  2020cites this paper
• Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden.

  2019cites this paper
• Analysis of Promoter-Associated Chromatin Interactions Reveals Biologically Relevant Candidate Target Genes at Endometrial Cancer Risk Loci

  2019cites this paper
• Genome-wide association study using diversity outcross mice identified candidate genes of pancreatic cancer.

  2019cites this paper
• Heterozygous mutations cause genetic instability in a yeast model of cancer evolution

  2019cites this paper
• ARID1B: From the Garden of Eden to the Sahara.

  2018cites this paper
• From copy number alterations to structural variants: the evolutionary cascade of papillary renal cell carcinomas

  2018cites this paper
• Sequencing a super multiple synchronous lung cancer reveals a novel variant in driver gene ARID1B

  2018cites this paper
• Epigenetic Vulnerabilities in Triple-Negative Breast Cancer

  2017cites this paper
• Genetic analysis of a morphologically heterogeneous ovarian endometrioid carcinoma

  2017cites this paper
• A potentially functional variant of ARID1B interacts with physical activity in association with risk of hepatocellular carcinoma

  2017cites this paper
• BRD9 Inhibition, Alone or in Combination with Cytostatic Compounds as a Therapeutic Approach in Rhabdoid Tumors

  2017cites this paper
• Differential gene expression profiles according to the Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society histopathological classification in lung adenocarcinoma subtypes.

  2017cites this paper
• High-depth, high-accuracy microsatellite genotyping enables precision lung cancer risk classification

  2017cites this paper
• Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer.

  2017cites this paper
• Functional Insights into Genic Neighbourhood Organization of Helitron Transposons in Bos taurus Genomes

  2017cites this paper
• Disruption of DNA Damage-Response by Propyl Gallate and 9-Aminoacridine.

  2016cites this paper
• Development of chemical probes for the bromodomains of BRD7 and BRD9.

  2016cites this paper
• Identifying candidate genes for 2p15p16.1 microdeletion syndrome using clinical, genomic, and functional analysis.

  2016cites this paper
• Chemical probes and inhibitors of bromodomains outside the BET family† †The authors declare no competing interests.

  2016cites this paper
• The Roles of SNF2/SWI2 Nucleosome Remodeling Enzymes in Blood Cell Differentiation and Leukemia

  2015cites this paper
• Facilitation of base excision repair by chromatin remodeling.

  2015cites this paper
• Mutations in ARID2 are associated with intellectual disabilities

  2015cites this paper
• SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non–Small Cell Lung Cancer

  2015cites this paper
• SMARCA 4 / BRG 1 is a novel prognostic biomarker predictive of cisplatin-based chemotherapy outcomes in resected non-small cell lung cancer

  2015cites this paper